Caresyntax
caresyntax raises $100 million to accelerate digitalisation of operating rooms
caresyntax raises $100 million to accelerate digitalisation of operating rooms
BERLIN & BOSTON, 28th April 2021 – caresyntax, the pioneer in digital surgery, hospital performance analytics, and AI, today announced it has raised $100 million in additional growth capital, one of the largest funding rounds in the German healthcare space to date. The Series C round was led by PFM Health Sciences LP, Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, along with current investors IPF Partners, Relyens Group and surgical.ai. The investment follows a year in which the company saw 250% growth, supported more than 30,000 surgeons, and improved care for more than 2 million patients. “We are grateful to our new and existing investors who support our vision of safer and smarter surgery,” said Björn von Siemens, caresyntax Co-Founder and CBO. “The last year accelerated the healthcare industry’s massive transformation of becoming a truly data-enabled and patient-centric space. We are excited to be at the forefront of the digital revolution in surgery.” Operating rooms are the financial heart of hospitals. They always need to perform as effectively and efficiently as possible – especially now with the surgical backlog resulting from the pandemic. caresyntax’s digital platforms use proprietary software and AI to analyse large volumes of real-world data in and around the OR. This delivers powerful insights that can be used by care teams and a variety of critical stakeholders that can then use the data to assess and improve care, and raise overall efficiency. The funding will allow caresyntax to accelerate its expansion in key markets, further develop its cutting-edge AI capabilities, and build out its platforms. “caresyntax is helping bend the curve towards better patient outcomes and more efficient workflow through extracting unique insights from structured and unstructured data in surgery,” said Dr. Anant Ahuja, Partner at PFM Health Sciences. “We are highly confident their technology platform will reduce clinical and business risks for all stakeholders in surgery, as it grows into a first-of-its-kind enterprise solution for data analytics in the operating room.” caresyntax’s growth comes at a critical time for hospitals. It is estimated that it could take up to a year to work through the surgical backlog, even operating at 10-20 percent above historical volume. Amidst the first wave of the COVID-19 pandemic, caresyntax offered hospitals the free-of-charge usage of its software to better manage scarce resources. Today’s funding announcement rounds off a year of successful new partnerships. Relyens Group, the largest European medical malpractice reinsurer, relies on caresyntax to help manage surgical risk, utilising its platform for real-world data-based assessments linked to patient outcomes. The University Hospital of Strasbourg has used caresyntax’s software applications to enable surgical training, which has led to better scores, an optimized learning curve, and improved risk management. Sheba Medical Center, the largest medical centre in the Middle East, signed a research partnership with caresyntax to predict surgical outcomes using AI and machine learning. Contact: Kekst CNC End of Media Release Issuer: Caresyntax Key word(s): Health
28.04.2021 Dissemination of a Press Release, transmitted by DGAP – a service of EQS Group AG. |